09.06.2015
- Israeli generics giant Teva appears to be seeking alternative strategies for achieving its targeted acquisition of Netherlands-based Mylan, following the company’s rejection of its...
29.05.2015
- Speculation that US pharmaceutical giant Pfizer, after a failed attempt last year to take over AstraZeneca, has its sights on GlaxoSmithKline (GSK) are gaining renewed attention...
29.05.2015
- Just before trial proceedings were to begin in a long-running dispute between the US Federal Trade Commission (FTC) and drugmaker Cephalon - now a subsidiary of Teva - the Israeli...
13.05.2015
- Former US-based generics producer Perrigo, now headquartered in Ireland, has acquired the Mexican operations of contract drug development and manufacturing services provider...
30.04.2015
- Still being pursued by Israeli generics giant Teva, Netherlands-based drugmaker Mylan has increased its offer to acquire the issued and to-be-issued shares of smaller generics...
28.04.2015
- In its first reaction to the hostile takeover bid by Israeli generics giant Teva, the board of Dutch-based drugmaker Mylan has unanimously rejected the more than $40 billion offer...
24.04.2015
- US-managed generics drugmaker Mylan, now domiciled in the Netherlands, is said to be preparing a "poison pill" defense to escape its pursuit by Israeli generics giant Teva. Teva...
22.04.2015
- In what is shaping up to be the global pharmaceutical industry's latest hostile takeover struggle, the world's largest generic drugmaker, Israel-based Teva, has made a bid for...
